GMRE — Global Medical REIT Cashflow Statement
0.000.00%
Last trade - 00:00- $428.37m
- $1.16bn
- $138.78m
- 44
- 66
- 24
- 40
Annual cashflow statement for Global Medical REIT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.5 | 18.3 | 20 | 21.7 | 6.69 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 8.35 | 7.66 | 1.65 | -5.56 | 7.23 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -7.65 | -3.82 | -1.74 | -5.69 | 1.21 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 34.5 | 69 | 76.5 | 68.4 | 70 |
| Capital Expenditures | -224 | -202 | -156 | -10 | -95.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.208 | 7 | 18.9 | 77.7 | 49.5 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -224 | -195 | -137 | 67.6 | -45.9 |
| Financing Cash Flow Items | -2.83 | -8.89 | -5.19 | 7.15 | 0.252 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 193 | 128 | 62.4 | -144 | -21.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.57 | 2.01 | 1.7 | -7.73 | 2.22 |